Relb Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
RELB is a member of the NF-κB transcription factor family that functions in the non-canonical NF-κB signaling pathway. RELB forms heterodimers with p100/NFKB2 and p52 to regulate genes involved in immune responses, cell survival, and inflammation. It is expressed in various tissues including the brain and plays important roles in neuroinflammation and neuronal survival .
| Attribute |
Value |
| Gene Symbol |
RELB |
| Protein Name |
Transcription Factor RelB |
| Alternative Names |
RELB, I-Rel |
| UniProt ID |
Q02880 |
| Molecular Weight |
~66 kDa |
| Protein Family |
NF-κB family, Rel subfamily |
| Subcellular Localization |
Nucleus (active), cytoplasm (inactive) |
RELB has characteristic Rel family features:
- RHD (Rel Homology Domain) — DNA binding and dimerization
- Transactivation domain — Gene activation capability
- Leucine zipper — Dimerization with other NF-κB members
- Nuclear localization signal — Nuclear import
RELB preferentially forms dimers with p100/p52 .
RELB regulates:
- Lymphoid organogenesis — Development of secondary lymphoid organs
- Adaptive immunity — B and T cell function
- Innate immunity — Dendritic cell maturation
- Inflammation — Specific inflammatory gene subsets
RELB controls:
- Anti-apoptotic genes — Bcl-xL, c-IAPs
- Differentiation — Myeloid cell differentiation
- Angiogenesis — VEGF regulation
- Cell migration — Matrix metalloproteinases
In neurons and glia:
- Astrocyte function — Regulates astrocyte inflammatory responses
- Microglial activation — Controls microglial phenotype
- Neuronal survival — Can be neuroprotective
- Blood-brain barrier — Regulates BBB integrity
RELB in AD:
- Neuroinflammation — Elevated in AD brain
- Aβ response — Activated by amyloid
- Glial activation — Promotes inflammatory phenotype
- Therapeutic target — Modulating RELB may reduce inflammation
- Neuroinflammation — Activated in PD substantia nigra
- Dopaminergic neurons — May protect or damage neurons
- Microglial polarization — Drives pro-inflammatory microglia
- Demyelination — RELB in oligodendrocyte death
- Autoimmunity — Central to MS pathology
- Ischemic injury — Activated after stroke
- Inflammation — Contributes to damage
Targeting RELB:
- NIK inhibitors — Block RELB activation
- Dimers formation blockers — Prevent p52/RELB dimerization
- Gene-specific targeting — More selective approaches
- PMID:8340146 — Discovery of RELB
- PMID:10625657 — RELB structure and function
- PMID:11025718 — Non-canonical NF-κB pathway
- PMID:14593116 — RELB in immune function
- PMID:15857886 — RELB in the brain
- PMID:21479819 — RELB in neurodegeneration
The study of Relb Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.